Re: more on how ER+her2+ breast cancer differs from ER-her2+ bc
if these findings are confirmed in larger numbers of patients, it may turn out that there is a subgroup of her2+ER+ breast cancer patients who do not need herceptin. It will only be a subgroup, and only that if these findings are confirmed in larger studies
|